2.2.0.25truefalse40304 - Disclosure - Acquisitions (Details)truefalseIn Millions, unless otherwise specifiedfalse1falsefalseUSDfalsefalse1/1/2010 - 12/31/2010
USD ($)
USD ($) / shares
$Duration_1_1_2010_To_12_31_2010http://www.sec.gov/CIK0000059478duration2010-01-01T00:00:002010-12-31T00:00:00Unit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit15Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0Unit1Standardhttp://www.xbrl.org/2003/instancesharesxbrli0Unit14Standardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$2falsefalseUSDfalsefalse1/1/2009 - 12/31/2009
USD ($)
USD ($) / shares
$Duration_1_1_2009_To_12_31_2009http://www.sec.gov/CIK0000059478duration2009-01-01T00:00:002009-12-31T00:00:00Unit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit1Standardhttp://www.xbrl.org/2003/instancesharesxbrli0Unit15Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0Unit14Standardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$3falsefalseUSDfalsefalse1/1/2008 - 12/31/2008
USD ($)
USD ($) / shares
$Duration_1_1_2008_To_12_31_2008http://www.sec.gov/CIK0000059478duration2008-01-01T00:00:002008-12-31T00:00:00Unit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit1Standardhttp://www.xbrl.org/2003/instancesharesxbrli0Unit14Standardhttp://www.xbrl.org/2003/instancepurexbrli0Unit15Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$4falsefalsetruefalse{us-gaap_BusinessAcquisitionAxis} : ImClone Systems, Inc. [Member]
{us-gaap_StatementGeographicalAxis} : United States [Member]
10/1/2008 - 12/31/2008
Duration_10_1_2008_To_12_31_20086http://www.sec.gov/CIK0000059478duration2008-10-01T00:00:002008-12-31T00:00:00falsefalseImClone Systems, Inc. [Member]us-gaap_BusinessAcquisitionAxisxbrldihttp://xbrl.org/2006/xbrldilly_ImcloneSystemsIncMemberus-gaap_BusinessAcquisitionAxisexplicitMemberfalsefalseUnited States [Member]us-gaap_StatementGeographicalAxisxbrldihttp://xbrl.org/2006/xbrldilly_UnitedStatesMemberus-gaap_StatementGeographicalAxisexplicitMemberUnit14Standardhttp://www.xbrl.org/2003/instancepurexbrli05falsefalsetruefalse{us-gaap_BusinessAcquisitionAxis} : ImClone Systems, Inc. [Member]
{us-gaap_StatementGeographicalAxis} : Outside the United States [Member]
10/1/2008 - 12/31/2008
Duration_10_1_2008_To_12_31_20085http://www.sec.gov/CIK0000059478duration2008-10-01T00:00:002008-12-31T00:00:00falsefalseImClone Systems, Inc. [Member]us-gaap_BusinessAcquisitionAxisxbrldihttp://xbrl.org/2006/xbrldilly_ImcloneSystemsIncMemberus-gaap_BusinessAcquisitionAxisexplicitMemberfalsefalseOutside the United States [Member]us-gaap_StatementGeographicalAxisxbrldihttp://xbrl.org/2006/xbrldilly_OutsideUnitedStatesMemberus-gaap_StatementGeographicalAxisexplicitMemberUnit14Standardhttp://www.xbrl.org/2003/instancepurexbrli06falsefalseUSDtruefalse{us-gaap_BusinessAcquisitionAxis} : Business Acquisition [Member]
1/1/2008 - 12/31/2008
USD ($)
$Duration_1_1_2008_To_12_31_20083http://www.sec.gov/CIK0000059478duration2008-01-01T00:00:002008-12-31T00:00:00falsefalseBusiness Acquisition [Member]us-gaap_BusinessAcquisitionAxisxbrldihttp://xbrl.org/2006/xbrldilly_BusinessAcquisitionMemberus-gaap_BusinessAcquisitionAxisexplicitMemberUnit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$7falsefalseUSDtruefalse{us-gaap_BusinessAcquisitionAxis} : Business Acquisition [Member]
12/31/2010
USD ($)
$As_Of_12_31_201058http://www.sec.gov/CIK0000059478instant2010-12-31T00:00:000001-01-01T00:00:00falsefalseBusiness Acquisition [Member]us-gaap_BusinessAcquisitionAxisxbrldihttp://xbrl.org/2006/xbrldilly_BusinessAcquisitionMemberus-gaap_BusinessAcquisitionAxisexplicitMemberUnit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$8falsefalseUSDtruefalse{us-gaap_BusinessAcquisitionAxis} : Avid Radiopharmaceuticals [Member]
12/31/2010
USD ($)
$As_Of_12_31_201057http://www.sec.gov/CIK0000059478instant2010-12-31T00:00:000001-01-01T00:00:00falsefalseAvid Radiopharmaceuticals [Member]us-gaap_BusinessAcquisitionAxisxbrldihttp://xbrl.org/2006/xbrldilly_AvidRadiopharmaceuticalsMemberus-gaap_BusinessAcquisitionAxisexplicitMemberUnit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$9falsefalseUSDtruefalse{us-gaap_BusinessAcquisitionAxis} : Alnara Pharmaceuticals [Member]
9/30/2010
USD ($)
$As_Of_9_30_2010http://www.sec.gov/CIK0000059478instant2010-09-30T00:00:000001-01-01T00:00:00falsefalseAlnara Pharmaceuticals [Member]us-gaap_BusinessAcquisitionAxisxbrldihttp://xbrl.org/2006/xbrldilly_AlnaraPharmaceuticalsMemberus-gaap_BusinessAcquisitionAxisexplicitMemberUnit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$10falsefalseUSDtruefalse{us-gaap_BusinessAcquisitionAxis} : Animal Health Sligo [Member]
6/30/2010
USD ($)
$As_Of_6_30_20102http://www.sec.gov/CIK0000059478instant2010-06-30T00:00:000001-01-01T00:00:00falsefalseAnimal Health Sligo [Member]us-gaap_BusinessAcquisitionAxisxbrldihttp://xbrl.org/2006/xbrldilly_AnimalHealthSligoMemberus-gaap_BusinessAcquisitionAxisexplicitMemberUnit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$11falsefalseUSDtruefalse{us-gaap_BusinessAcquisitionAxis} : ImClone Systems, Inc. [Member]
10/1/2008 - 12/31/2008
USD ($)
$Duration_10_1_2008_To_12_31_20082http://www.sec.gov/CIK0000059478duration2008-10-01T00:00:002008-12-31T00:00:00falsefalseImClone Systems, Inc. [Member]us-gaap_BusinessAcquisitionAxisxbrldihttp://xbrl.org/2006/xbrldilly_ImcloneSystemsIncMemberus-gaap_BusinessAcquisitionAxisexplicitMemberUnit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit14Standardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$12falsefalseUSDtruefalse{us-gaap_BusinessAcquisitionAxis} : Erbitux (ImClone) [Member]
10/1/2008 - 12/31/2008
USD ($)
$Duration_10_1_2008_To_12_31_2008http://www.sec.gov/CIK0000059478duration2008-10-01T00:00:002008-12-31T00:00:00falsefalseErbitux (ImClone) [Member]us-gaap_BusinessAcquisitionAxisxbrldihttp://xbrl.org/2006/xbrldilly_ErbituxImcloneMemberus-gaap_BusinessAcquisitionAxisexplicitMemberUnit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$13falsefalseUSDtruefalse{us-gaap_BusinessAcquisitionAxis} : Posilac & SGX [Member]
12/31/2008
USD ($)
$As_Of_12_31_20085http://www.sec.gov/CIK0000059478instant2008-12-31T00:00:000001-01-01T00:00:00falsefalsePosilac & SGX [Member]us-gaap_BusinessAcquisitionAxisxbrldihttp://xbrl.org/2006/xbrldilly_PosilacSgxMemberus-gaap_BusinessAcquisitionAxisexplicitMemberUnit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$14falsefalseUSDtruefalse{us-gaap_BusinessAcquisitionAxis} : Posilac [Member]
12/31/2008
USD ($)
$As_Of_12_31_20084http://www.sec.gov/CIK0000059478instant2008-12-31T00:00:000001-01-01T00:00:00falsefalsePosilac [Member]us-gaap_BusinessAcquisitionAxisxbrldihttp://xbrl.org/2006/xbrldilly_PosilacMemberus-gaap_BusinessAcquisitionAxisexplicitMemberUnit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$15falsefalseUSDtruefalse{us-gaap_BusinessAcquisitionAxis} : SGX [Member]
9/30/2008
USD ($)
$As_Of_9_30_2008http://www.sec.gov/CIK0000059478instant2008-09-30T00:00:000001-01-01T00:00:00falsefalseSGX [Member]us-gaap_BusinessAcquisitionAxisxbrldihttp://xbrl.org/2006/xbrldilly_SgxMemberus-gaap_BusinessAcquisitionAxisexplicitMemberUnit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$16falsefalseUSDtruefalse{us-gaap_BusinessAcquisitionAxis} : Asset Acquiisition [Member]
1/1/2010 - 12/31/2010
USD ($)
$Duration_1_1_2010_To_12_31_20102http://www.sec.gov/CIK0000059478duration2010-01-01T00:00:002010-12-31T00:00:00falsefalseAsset Acquiisition [Member]us-gaap_BusinessAcquisitionAxisxbrldihttp://xbrl.org/2006/xbrldilly_AssetAcquiisitionMemberus-gaap_BusinessAcquisitionAxisexplicitMemberUnit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$17falsefalseUSDtruefalse{us-gaap_BusinessAcquisitionAxis} : Asset Acquiisition [Member]
1/1/2009 - 12/31/2009
USD ($)
$Duration_1_1_2009_To_12_31_20092http://www.sec.gov/CIK0000059478duration2009-01-01T00:00:002009-12-31T00:00:00falsefalseAsset Acquiisition [Member]us-gaap_BusinessAcquisitionAxisxbrldihttp://xbrl.org/2006/xbrldilly_AssetAcquiisitionMemberus-gaap_BusinessAcquisitionAxisexplicitMemberUnit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$18falsefalseUSDtruefalse{us-gaap_BusinessAcquisitionAxis} : Asset Acquiisition [Member]
1/1/2008 - 12/31/2008
USD ($)
$Duration_1_1_2008_To_12_31_20082http://www.sec.gov/CIK0000059478duration2008-01-01T00:00:002008-12-31T00:00:00falsefalseAsset Acquiisition [Member]us-gaap_BusinessAcquisitionAxisxbrldihttp://xbrl.org/2006/xbrldilly_AssetAcquiisitionMemberus-gaap_BusinessAcquisitionAxisexplicitMemberUnit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$19falsefalseUSDtruefalse{us-gaap_BusinessAcquisitionAxis} : TransPharma Medical Ltd. [Member]
4/1/2008 - 6/30/2008
USD ($)
$Duration_4_1_2008_To_6_30_2008http://www.sec.gov/CIK0000059478duration2008-04-01T00:00:002008-06-30T00:00:00falsefalseTransPharma Medical Ltd. [Member]us-gaap_BusinessAcquisitionAxisxbrldihttp://xbrl.org/2006/xbrldilly_TranspharmaMedicalLtdMemberus-gaap_BusinessAcquisitionAxisexplicitMemberUnit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$20falsefalseUSDtruefalse{us-gaap_BusinessAcquisitionAxis} : InCyte Corporation [Member]
10/1/2009 - 12/31/2009
USD ($)
$Duration_10_1_2009_To_12_31_2009http://www.sec.gov/CIK0000059478duration2009-10-01T00:00:002009-12-31T00:00:00falsefalseInCyte Corporation [Member]us-gaap_BusinessAcquisitionAxisxbrldihttp://xbrl.org/2006/xbrldilly_IncyteCorporationMemberus-gaap_BusinessAcquisitionAxisexplicitMemberUnit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$21falsefalseUSDtruefalse{us-gaap_BusinessAcquisitionAxis} : Acrux Limited [Member]
1/1/2010 - 3/31/2010
USD ($)
$Duration_1_1_2010_To_3_31_2010http://www.sec.gov/CIK0000059478duration2010-01-01T00:00:002010-03-31T00:00:00falsefalseAcrux Limited [Member]us-gaap_BusinessAcquisitionAxisxbrldihttp://xbrl.org/2006/xbrldilly_AcruxLimitedMemberus-gaap_BusinessAcquisitionAxisexplicitMemberUnit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$22falsefalseUSDtruefalse{us-gaap_BusinessAcquisitionAxis} : BioMS Medical Corp. [Member]
1/1/2008 - 3/31/2008
USD ($)
$Duration_1_1_2008_To_3_31_2008http://www.sec.gov/CIK0000059478duration2008-01-01T00:00:002008-03-31T00:00:00falsefalseBioMS Medical Corp. [Member]us-gaap_BusinessAcquisitionAxisxbrldihttp://xbrl.org/2006/xbrldilly_BiomsMedicalCorpMemberus-gaap_BusinessAcquisitionAxisexplicitMemberUnit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false0us-gaap_BusinessAcquisitionCostOfAcquiredEntityPurchasePriceus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8truefalsefalse346100000346.1falsetruefalsetruefalse9truefalsefalse291700000291.7falsetruefalsetruefalse10truefalsefalse148400000148.4falsetruefalsetruefalse11truefalsefalse65000000006500.0falsetruefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15truefalsefalse6680000066.8falsetruefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalse17falsefalsefalse00falsefalsefalsetruefalse18falsefalsefalse00falsefalsefalsetruefalse19falsefalsefalse00falsefalsefalsetruefalse20falsefalsefalse00falsefalsefalsetruefalse21falsefalsefalse00falsefalsefalsetruefalse22falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryThe total cost of the acquired entity including the cash paid to shareholders of acquired entities, fair value of debt and equity securities issued to shareholders of acquired entities, the fair value of the liabilities assumed, and direct costs of the acquisition.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 51
-Subparagraph d
truefalse3false0us-gaap_BusinessAcquisitionCostOfAcquiredEntityCashPaidus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8truefalsefalse286300000286.3falsefalsefalsetruefalse9truefalsefalse188700000188.7falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11falsefalsefalse00falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14truefalsefalse300000000300.0falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalse17falsefalsefalse00falsefalsefalsetruefalse18falsefalsefalse00falsefalsefalsetruefalse19falsefalsefalse00falsefalsefalsetruefalse20falsefalsefalse00falsefalsefalsetruefalse21falsefalsefalse00falsefalsefalsetruefalse22falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryAmount of cash paid to acquire the entity.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 68
-Subparagraph f(1)
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 51
-Subparagraph d
falsefalse4false0us-gaap_BusinessAcquisitionContingentConsiderationPotentialCashPaymentus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8truefalsefalse550000000550.0falsefalsefalsetruefalse9truefalsefalse200000000200.0falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11falsefalsefalse00falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalse17falsefalsefalse00falsefalsefalsetruefalse18falsefalsefalse00falsefalsefalsetruefalse19falsefalsefalse00falsefalsefalsetruefalse20falsefalsefalse00falsefalsefalsetruefalse21falsefalsefalse00falsefalsefalsetruefalse22falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryAmount of potential cash payments that could result from the contingent consideration arrangement.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 51
-Subparagraph f
falsefalse5false0us-gaap_BusinessAcquisitionContingentConsiderationAtFairValueus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8truefalsefalse5980000059.8falsefalsefalsetruefalse9truefalsefalse103000000103.0falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11falsefalsefalse00falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalse17falsefalsefalse00falsefalsefalsetruefalse18falsefalsefalse00falsefalsefalsetruefalse19falsefalsefalse00falsefalsefalsetruefalse20falsefalsefalse00falsefalsefalsetruefalse21falsefalsefalse00falsefalsefalsetruefalse22falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryFair value, as of the acquisition date, of potential payments under the contingent consideration arrangement including cash and shares.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 68
-Subparagraph g(1)
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 51
-Subparagraph f
Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 29, 30, 41, 42, 64
Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 65
-Subparagraph a, b
falsefalse6false0us-gaap_BusinessAcquisitionPurchasePriceAllocationCurrentAssetsCashAndCashEquivalentsus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11truefalsefalse982900000982.9falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalse17falsefalsefalse00falsefalsefalsetruefalse18falsefalsefalse00falsefalsefalsetruefalse19falsefalsefalse00falsefalsefalsetruefalse20falsefalsefalse00falsefalsefalsetruefalse21falsefalsefalse00falsefalsefalsetruefalse22falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryThe amount of cash and cash equivalents acquired in a business combination.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 51
-Subparagraph e
falsefalse7false0us-gaap_BusinessAcquisitionPurchasePriceAllocationCurrentAssetsInventoryus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11truefalsefalse136200000136.2falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13truefalsefalse167600000167.6falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalse17falsefalsefalse00falsefalsefalsetruefalse18falsefalsefalse00falsefalsefalsetruefalse19falsefalsefalse00falsefalsefalsetruefalse20falsefalsefalse00falsefalsefalsetruefalse21falsefalsefalse00falsefalsefalsetruefalse22falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryThe amount of acquisition cost of a business combination allocated to inventory, including finished goods, work-in-process, and raw materials.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 51
-Subparagraph e
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 37
-Subparagraph c
falsefalse8false0us-gaap_BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssetsus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8truefalsefalse334000000334.0falsefalsefalsetruefalse9truefalsefalse264000000264.0falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11truefalsefalse10579000001057.9falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13truefalsefalse210000000210.0falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalse17falsefalsefalse00falsefalsefalsetruefalse18falsefalsefalse00falsefalsefalsetruefalse19falsefalsefalse00falsefalsefalsetruefalse20falsefalsefalse00falsefalsefalsetruefalse21falsefalsefalse00falsefalsefalsetruefalse22falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryThe amount of acquisition cost of a business combination allocated to an identifiable intangible asset that will be amortized.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 52
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 51
-Subparagraph e
falsefalse9false0us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillAmountus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8truefalsefalse132500000132.5falsefalsefalsetruefalse9truefalsefalse100500000100.5falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11truefalsefalse425900000425.9falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalse17falsefalsefalse00falsefalsefalsetruefalse18falsefalsefalse00falsefalsefalsetruefalse19falsefalsefalse00falsefalsefalsetruefalse20falsefalsefalse00falsefalsefalsetruefalse21falsefalsefalse00falsefalsefalsetruefalse22falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryAmount of goodwill arising from a business combination, which is the excess of the cost of the acquired entity over the amounts assigned to assets acquired and liabilities assumed.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 52
-Subparagraph c
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 53
-Subparagraph d
falsefalse10false0us-gaap_BusinessAcquisitionPurchasePriceAllocationPropertyPlantAndEquipmentus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11truefalsefalse338900000338.9falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13truefalsefalse102800000102.8falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalse17falsefalsefalse00falsefalsefalsetruefalse18falsefalsefalse00falsefalsefalsetruefalse19falsefalsefalse00falsefalsefalsetruefalse20falsefalsefalse00falsefalsefalsetruefalse21falsefalsefalse00falsefalsefalsetruefalse22falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryThe amount of acquisition cost of a business combination allocated to property, plant and equipment to be used in ongoing operations.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 51
-Subparagraph e
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 37
-Subparagraph d
falsefalse11false0us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilitiesus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11truefalsefalse-600000000-600.0falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalse17falsefalsefalse00falsefalsefalsetruefalse18falsefalsefalse00falsefalsefalsetruefalse19falsefalsefalse00falsefalsefalsetruefalse20falsefalsefalse00falsefalsefalsetruefalse21falsefalsefalse00falsefalsefalsetruefalse22falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryThe amount of financial liabilities assumed (as defined) which have been recognized as of the acquisition date.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 12, 13, 14, 20, A107
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 68
-Subparagraph i
falsefalse12false0us-gaap_BusinessAcquisitionPurchasePriceAllocationDeferredIncomeTaxesAssetLiabilityNetus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsetruenegated1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8truefalsefalse116900000116.9falsefalsefalsetruefalse9truefalsefalse9240000092.4falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11truefalsefalse311500000311.5falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalse17falsefalsefalse00falsefalsefalsetruefalse18falsefalsefalse00falsefalsefalsetruefalse19falsefalsefalse00falsefalsefalsetruefalse20falsefalsefalse00falsefalsefalsetruefalse21falsefalsefalse00falsefalsefalsetruefalse22falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryAmount of deferred tax assets or liabilities for the differences between the values assigned and the tax bases of assets and liabilities in a business combination, net of any valuation allowance for deferred tax assets.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 51
-Subparagraph e
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 38
falsefalse13false0us-gaap_BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesDeferredRevenueus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11truefalsefalse-127700000-127.7falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalse17falsefalsefalse00falsefalsefalsetruefalse18falsefalsefalse00falsefalsefalsetruefalse19falsefalsefalse00falsefalsefalsetruefalse20falsefalsefalse00falsefalsefalsetruefalse21falsefalsefalse00falsefalsefalsetruefalse22falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryThe amount of acquisition cost of a business combination allocated to deferred revenue of the acquired entity.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Emerging Issues Task Force (EITF)
-Number 01-3
falsefalse14false0us-gaap_BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesOtherLiabilitiesus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11falsefalsefalse00falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13truefalsefalse133100000133.1falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalse17falsefalsefalse00falsefalsefalsetruefalse18falsefalsefalse00falsefalsefalsetruefalse19falsefalsefalse00falsefalsefalsetruefalse20falsefalsefalse00falsefalsefalsetruefalse21falsefalsefalse00falsefalsefalsetruefalse22falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryThe amount of acquisition cost of a business combination allocated to other current liabilities of the acquired entity. Does not include amounts allocated to the current portion of long-term debt, accounts payable and accrued expenses.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 51
-Subparagraph e
falsefalse15false0lly_BusinessCombinationPurchasePriceAllocationOtherAssetsAndLiabilitiesNetllyfalsedebitinstantOther assets and liabilities, net, acquired in a business combination, not otherwise allocated.falsefalsefalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11truefalsefalse-92600000-92.6falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalse17falsefalsefalse00falsefalsefalsetruefalse18falsefalsefalse00falsefalsefalsetruefalse19falsefalsefalse00falsefalsefalsetruefalse20falsefalsefalse00falsefalsefalsetruefalse21falsefalsefalse00falsefalsefalsetruefalse22falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryOther assets and liabilities, net, acquired in a business combination, not otherwise allocated.No authoritative reference available.falsefalse16false0lly_BusinessAcquisitionPurchasePriceAllocationAcquiredInProcessResearchAndDevelopmentllyfalsedebitinstantThe amount of the total purchase prices allocated to purchased research and development assets that are acquired in a...falsefalsefalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11truefalsefalse46900000004690.0falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalse17falsefalsefalse00falsefalsefalsetruefalse18falsefalsefalse00falsefalsefalsetruefalse19falsefalsefalse00falsefalsefalsetruefalse20falsefalsefalse00falsefalsefalsetruefalse21falsefalsefalse00falsefalsefalsetruefalse22falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryThe amount of the total purchase prices allocated to purchased research and development assets that are acquired in a business combination that have no alternative future use and are therefore written off in the period of acquisition.No authoritative reference available.falsefalse17false0lly_AcquiredInProcessResearchAndDevelopmentPortionAttributableToCertainAssetsllyfalsenadurationAcquired in-process research and development, portion attributable to other compoundsfalsefalsefalsefalsefalsefalsefalsefalsefalsefalselabel1falsetruefalse00falsefalsefalsefalsefalse2falsetruefalse00falsefalsefalsefalsefalse3falsetruefalse00falsefalsefalsefalsefalse4falsetruefalse00falsefalsefalsetruefalse5falsetruefalse00falsefalsefalsetruefalse6falsetruefalse00falsefalsefalsetruefalse7falsetruefalse00falsefalsefalsetruefalse8falsetruefalse00falsefalsefalsetruefalse9falsetruefalse00falsefalsefalsetruefalse10falsetruefalse00falsefalsefalsetruefalse11truetruefalse0.810.81falsefalsefalsetruefalse12falsetruefalse00falsefalsefalsetruefalse13falsetruefalse00falsefalsefalsetruefalse14falsetruefalse00falsefalsefalsetruefalse15falsetruefalse00falsefalsefalsetruefalse16falsetruefalse00falsefalsefalsetruefalse17falsetruefalse00falsefalsefalsetruefalse18falsetruefalse00falsefalsefalsetruefalse19falsetruefalse00falsefalsefalsetruefalse20falsetruefalse00falsefalsefalsetruefalse21falsetruefalse00falsefalsefalsetruefalse22falsetruefalse00falsefalsefalsetruefalseOtherus-types:percentItemTypepureAcquired in-process research and development, portion attributable to other compoundsNo authoritative reference available.falsefalse18false0us-gaap_FiniteLivedIntangibleAssetsUsefulLifeus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4truefalsefalse20232023falsefalsefalsetruefalse5truefalsefalse20182018falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11falsefalsefalse00falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalse17falsefalsefalse00falsefalsefalsetruefalse18falsefalsefalse00falsefalsefalsetruefalse19falsefalsefalse00falsefalsefalsetruefalse20falsefalsefalse00falsefalsefalsetruefalse21falsefalsefalse00falsefalsefalsetruefalse22falsefalsefalse00falsefalsefalsetruefalseOtherxbrli:integerItemTypeintegerThe useful life of all finite-lived intangible assets. This may be stated as a fixed number (for example, 10 years) if all assets have the same useful life, or it can be stated in a range (for example, six to eight years) if there is a range of useful lives in the asset group.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 142
-Paragraph 12, 13, 14
falsefalse19false0lly_AcquiredInProcessResearchAndDevelopmentllyfalsedebitdurationThe amount of purchased research and development assets that are acquired in a business combination and/or licensing...falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse5000000050.0falsefalsefalsefalsefalse2truefalsefalse9000000090.0falsefalsefalsefalsefalse3truefalsefalse48354000004835.4falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalse5falsefalsefalse00falsefalsefalsetruefalse6truefalsefalse47100000004710.0falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11truefalsefalse46900000004690.0falsefalsefalsetruefalse12truefalsefalse13300000001330.0falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16truefalsefalse5000000050.0falsefalsefalsetruefalse17truefalsefalse9000000090.0falsefalsefalsetruefalse18truefalsefalse122000000122.0falsefalsefalsetruefalse19truefalsefalse3500000035.0falsefalsefalsetruefalse20truefalsefalse9000000090.0falsefalsefalsetruefalse21truefalsefalse5000000050.0falsefalsefalsetruefalse22truefalsefalse8700000087.0falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryThe amount of purchased research and development assets that are acquired in a business combination and/or licensing arrangement that have no alternative future use and are therefore written off in the period of acquisition.No authoritative reference available.falsefalse20false0us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangiblesus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7truefalsefalse598000000598.0falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10truefalsefalse7620000076.2falsefalsefalsetruefalse11falsefalsefalse00falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalse17falsefalsefalse00falsefalsefalsetruefalse18falsefalsefalse00falsefalsefalsetruefalse19falsefalsefalse00falsefalsefalsetruefalse20falsefalsefalse00falsefalsefalsetruefalse21falsefalsefalse00falsefalsefalsetruefalse22falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryThe amount of identifiable intangible assets recognized as of the acquisition date.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 12, 13, 14, 20, A107
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 68
-Subparagraph i
falsefalse21false0us-gaap_BusinessAcquisitionProFormaRevenueus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11truefalsefalse2073220000020732.2falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalse17falsefalsefalse00falsefalsefalsetruefalse18falsefalsefalse00falsefalsefalsetruefalse19falsefalsefalse00falsefalsefalsetruefalse20falsefalsefalse00falsefalsefalsetruefalse21falsefalsefalse00falsefalsefalsetruefalse22falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryThe pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the periodReference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 68
-Subparagraph r(2, 3)
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 54
Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 55
falsefalse22false0us-gaap_BusinessAcquisitionProFormaNetIncomeLossus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11truefalsefalse23562000002356.2falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalse17falsefalsefalse00falsefalsefalsetruefalse18falsefalsefalse00falsefalsefalsetruefalse19falsefalsefalse00falsefalsefalsetruefalse20falsefalsefalse00falsefalsefalsetruefalse21falsefalsefalse00falsefalsefalsetruefalse22falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryThe pro forma net income (loss) for the period as if the business combination or combinations had been completed at the beginning of a periodReference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 68
-Subparagraph r(2, 3)
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 54
Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 55
falsefalse23false0lly_BusinessAcquisitionProFormaEarningsPerShareBasicAndDilutedllyfalsenadurationThe pro forma basic and diluted net income per share for a period as if the business combination or combinations had been...falsefalsefalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11truefalsefalse2.152.15falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalse17falsefalsefalse00falsefalsefalsetruefalse18falsefalsefalse00falsefalsefalsetruefalse19falsefalsefalse00falsefalsefalsetruefalse20falsefalsefalse00falsefalsefalsetruefalse21falsefalsefalse00falsefalsefalsetruefalse22falsefalsefalse00falsefalsefalsetruefalseOtherxbrli:decimalItemTypedecimalThe pro forma basic and diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a periodNo authoritative reference available.falsefalse24false0lly_BusinessAcquisitionProFormaDeferredIncomeAmortizationllyfalsedebitdurationThis element represents the reduction of the amortization of the acquiree's deferred income.falsefalsefalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11truefalsefalse8620000086.2falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalse17falsefalsefalse00falsefalsefalsetruefalse18falsefalsefalse00falsefalsefalsetruefalse19falsefalsefalse00falsefalsefalsetruefalse20falsefalsefalse00falsefalsefalsetruefalse21falsefalsefalse00falsefalsefalsetruefalse22falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryThis element represents the reduction of the amortization of the acquiree's deferred income.No authoritative reference available.falsefalse25false0lly_BusinessAcquisitionProFormaAmortizationExpensellyfalsedebitdurationThis element represents the increase of amortization expense of the acquiree.falsefalsefalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11truefalsefalse7880000078.8falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalse17falsefalsefalse00falsefalsefalsetruefalse18falsefalsefalse00falsefalsefalsetruefalse19falsefalsefalse00falsefalsefalsetruefalse20falsefalsefalse00falsefalsefalsetruefalse21falsefalsefalse00falsefalsefalsetruefalse22falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryThis element represents the increase of amortization expense of the acquiree.No authoritative reference available.falsefalse26false0lly_BusinessAcquisitionProFormaInterestExpensellyfalsedebitdurationThis element represents the adjustment to interest expense for pro forma presentation.falsefalsefalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11truefalsefalse301000000301.0falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalse17falsefalsefalse00falsefalsefalsetruefalse18falsefalsefalse00falsefalsefalsetruefalse19falsefalsefalse00falsefalsefalsetruefalse20falsefalsefalse00falsefalsefalsetruefalse21falsefalsefalse00falsefalsefalsetruefalse22falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryThis element represents the adjustment to interest expense for pro forma presentation.No authoritative reference available.falsefalse27false0lly_BusinessAcquisitionProFormaIncomeTaxExpensellyfalsedebitdurationThis element represents the adjustment of acquiree's tax rate to acquirer's tax rate.falsefalsefalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11truefalsefalse139300000139.3falsetruefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalse17falsefalsefalse00falsefalsefalsetruefalse18falsefalsefalse00falsefalsefalsetruefalse19falsefalsefalse00falsefalsefalsetruefalse20falsefalsefalse00falsefalsefalsetruefalse21falsefalsefalse00falsefalsefalsetruefalse22falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryThis element represents the adjustment of acquiree's tax rate to acquirer's tax rate.No authoritative reference available.falsefalse2226Acquisitions (Details) (USD $)HundredThousandsUnKnownUnKnownUnKnowntruetrue
